Nicola Canessa, Giuseppe Pantaleo, Chiara Crespi, Alessandra Gorini, Stefano F Cappa
The impact of egocentric vs. allocentric agency attributions on the neural bases of reasoning about social rules
Brain research
patients type 2 diabetes t2dm increasing need personalized precise management medical technology advances artificial intelligence ai technologies mobile devices developed gradually variety healthcare fields ai field knowledge graph kg developed extract store structured knowledge massive data sets great prospects t2dm medical information retrieval clinical decisionmaking individual intelligent question answering qa yet thoroughly researched t2dm intervention therefore designed artificial intelligencebased health education accurately linking system aiheals evaluate aihealsbased intervention could help patients t2dm improve selfmanagement abilities blood glucose control primary healthcare nested mixedmethod study includes communitybased clusterrandomized control trial personal indepth interviews individuals t2dm ages 18 75 recruited 4045 community health centers beijing china participants either receive standard diabetes primary care sdpc control 3 months sdpc plus aiheals online health education program intervention 3 months aiheals runs wechat service platform includes kbqa system physiological indicators lifestyle recording monitoring medication blood glucose monitoring reminders automated personalized message sending data sociodemography medical examination blood glucose selfmanagement behavior collected baseline well 13612 18 months later primary outcome reduce hba1c levels secondary outcomes include changes selfmanagement behavior social cognition psychology t2dm skills health literacy furthermore costeffectiveness aihealsbased intervention evaluated kbqa system innovative costeffective technology health education promotion t2dm patients yet widely used t2dm interventions trial provide evidence efficacy ai mhealthbased personalized interventions primary care improving t2dm outcomes selfmanagement behaviors biomedical ethics committee peking university irb0000105222058 20220606 clinical trials chictr2300068952 02032023